rawfin.tv
Rani Therapeutics CTO Reports Stock Sale and Tax Withholding
MarketsstocksAI Generated

Rani Therapeutics CTO Reports Stock Sale and Tax Withholding

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Rani Therapeutics' Chief Technical Officer, Alireza Javadi, disclosed two dispositions of Class A Common Stock. These transactions included both stock sales and tax withholdings, as reported in recent filings.

insider-tradingbiotechstock-saleexecutive-compensation

Related Articles

S&P 500 Heavyweights Face Earnings Test Amid Fed Meeting

S&P 500 Heavyweights Face Earnings Test Amid Fed Meeting

stocks
China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks